Finance

Beta
Lists
600420:SHA
Shanghai Shyndec Pharmaceutical Co Ltd
CN¥8.96
+1.01%
(+0.090) 1D
Jun 5, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600420...
Open
CN¥8.90
High
CN¥9.01
Low
CN¥8.88
Mkt. cap
12.02B
Avg. vol.
6.68M
Volume
3.48M
Dividend
3.35%
Quarterly dividend
CN¥0.08
Ex-dividend date
Jun 3, 2026
P/E ratio
16.72
52-wk high
CN¥11.80
52-wk low
CN¥8.85
EPS
CN¥0.54
Shares outstanding
1.06B
No. of employees
10K
Open
CN¥8.90
High
CN¥9.01
Low
CN¥8.88
Mkt. cap
12.02B
Avg. vol.
6.68M
Volume
3.48M
Dividend
3.35%
Quarterly dividend
CN¥0.08
Ex-dividend date
Jun 3, 2026
P/E ratio
16.72
52-wk high
CN¥11.80
52-wk low
CN¥8.85
EPS
CN¥0.54
Shares outstanding
1.06B
No. of employees
10K
News stories
From sources across the web
About Shanghai Shyndec Pharmaceutical Co Ltd
CEO-
Employees9.7K
FoundedNov 27, 1996
Headquarters-
SectorPharmaceutical industry
Websiteshyndec.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.27B
2.04B
2.44B
2.06B
Cost of goods sold
1.52B
1.45B
1.82B
1.44B
Cost of revenue
1.52B
1.45B
1.82B
1.44B
Research and development expenses
117.22M
103.68M
105.95M
78.82M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
252.73M
274.94M
399.48M
278.47M
Operating expense
396.58M
372.50M
563.58M
374.72M
Total operating expenses
1.92B
1.83B
2.38B
1.82B
Operating income
351.24M
216.70M
57.91M
248.68M
Other non operating income
-6.99M
18.17M
-20.75M
-12.37M
EBT including unusual items
413.88M
190.56M
212.10M
248.32M
EBT excluding unusual items
386.34M
260.01M
111.77M
270.29M
Income tax expense
67.24M
27.51M
3.16M
56.18M
Effective tax rate
16.25%
14.44%
1.49%
22.62%
Other operating expenses
23.60M
-8.58M
59.46M
8.61M
Net income
310.65M
129.10M
140.43M
138.40M
Net profit margin
13.68%
6.32%
5.75%
6.70%
Earnings per share
-
-
-
-
Interest and investment income
32.52M
37.46M
72.55M
34.52M
Interest expense
-1.44M
-1.32M
-223.56K
-538.23K
Net interest expenses
31.08M
36.14M
72.32M
33.98M
Depreciation and amortization charges
-
-
-
-
EBITDA
521.72M
404.71M
232.56M
423.32M
Gain or loss from assets sale
65.42K
-65.42K
2.65M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer